Questions & Answers
Influenza - Seasonal - Policy and Management
Back to All Influenza - Seasonal Q&A Back to All Q&A Back to Influenza - Seasonal

Questions
Answers

Department of Defense (DoD) Seasonal Influenza Vaccination Program (IVP)

  1. Who does the Advisory Committee on Immunization Practices (ACIP), recommend receive an annual influenza vaccination?

    ACIP recommends the use of the seasonal influenza vaccinations for all people 6 months and older. Additionally, emphasis on providing routine annual vaccinations to certain groups at higher risk for influenza infection or complications should be a priority:

    • Anyone who is at risk of complications from influenza, or more likely to require medical care.
    • Women who will be pregnant during influenza season.
    • Anyone with long-term health problems including heart disease, kidney disease, liver disease, lung disease, metabolic disease (diabetes), asthma, anemia and other blood disorders.
    • Anyone with a weakened immune system, long-term treatment with drugs such as steroids, and cancer treatment with x-rays or drugs.
    • Anyone with certain muscle or nerve disorders (such as spinal cord injuries, seizure disorders or cerebral palsy) that can lead to breathing or swallowing problems.
    • Anyone 6 months through 18 years of age on long-term aspirin treatment.
    • Residents of nursing homes and other chronic-care facilities.
    • Anyone who lives with or cares for people at high risk for influenza-related complications.
    • Health care providers.
    • Household contacts and caregivers of children from 0-5 years of age and people 50 years and older.


  2. When will the IVP begin?

    Vaccine shipments occur in early August. Your installation seasonal influenza vaccine program should begin immediately upon receipt of influenza vaccine to protect individuals at risk from developing influenza or its complications. All Services will follow Service-specific implementation guidelines. Influenza vaccinations should continue until supply is exhausted or the vaccine expiration is reached.



  3. What documentation is required with influenza immunization?

    It is important to document immunizations properly into electronic immunization and paper-based systems. Vaccine, date of administration, lot number, manufacturer, Vaccine Information Statement version date, name of vaccine administrator and medical exemptions for military personnel must be documented in Service-specific immunization tracking systems.

    All Services will monitor implementation using Service-specific electronic immunization tracking systems (Medical Protection System (MEDPROS), Aeromedical Services Information Management System (ASIMS), Medical Readiness Reporting System (MRRS), Shipboard Automated Medical System (SAMS), and the Defense Eligibility Enrollment Reporting System (DEERS). All Military Health System (MHS) beneficiary immunizations should be documented in the electronic health record.



  4. Where did the DoD get this year's influenza vaccine?

    DoD has arranged with the Defense Logistics Agency – Troop Support (DLA-TS) to contract for influenza vaccine from four different manufacturers. Three manufacturers will provide injectable trivalent inactivated influenza vaccine (IIV3), Sanofi-Pasteur (Fluzone®), CSL Biotherapies/Merck (Afluria®), and Novartis (Fluvirin® and Flucelvax®). MedImmune (FluMist®) produces the intranasal quadravalent live, attenuated influenza vaccine (LAIV4).

    Note: More information regarding this year's influenza vaccines and the presentations available can be found at www.vaccines.mil/documents/1642_Influenza_Vaccines_for_Different_Age_Groups_-_2013-14.pdf



  5. Which personnel are required to receive the influenza vaccine?
    DoD policy requires annual influenza immunizations for all Active Duty, National Guard and Reserve personnel, and health care personnel who provide direct patient care according to Service-specific guidelines.

  6. Will my immunization be monitored by my Service?
    Yes. All Services will monitor implementation using Service-specific immunization tracking systems (MEDPROS, ASIMS, MRRS, and SAMS).

  7. What is the current DoD Seasonal Influenza policy and who should be vaccinated?

    DoD policy states influenza immunizations are mandatory for all Active Duty, National Guard, and Reserve personnel. Influenza immunizations are mandatory for DoD civilian and contract health care personnel who provide direct patient care at military treatment facilities (MTFs).

    Note: more information on DoD influenza policies can be found at www.vaccines.mil/Policies/Influenza_-_Seasonal.

    The Office of the Assistant Secretary of Defense for Health Affairs (HA) Policy 08-005, dated 4 April 2008, mandates all civilian health care personnel who provide direct care to patients in medical treatment facilities must be immunized against seasonal influenza each year as a condition of employment. www.vaccines.mil/documents/1169HCPFluHAPolicy_08_005.pdf.



  8. Who should receive the influenza vaccine and in what order if there is a shortage?
    Should an unanticipated shortage of vaccine occur, HA will provide further direction regarding priority tiers, consistent with recommendations published in the Centers for Disease Control and Prevention (CDC's) Morbidity and Mortality Weekly Report.

  9. Who can I contact if I have a problem after receiving my vaccine?

    If you are having a medical emergency call 911. Contact your healthcare provider or the clinic at which you received your vaccination for appropriate follow-up.

    You may also contact the the DoD 24/7 Vaccine Healthcare Centers Network at (866) 210-6469 or email via at https://askIHB.wramc.amedd.army.mil. Any clinically significant medical event that occurs after vaccination should be submitted to the Vaccine Adverse Event Reporting System (VAERS) at www.vaers.hhs.gov.



  10. What is the primary goal of DoD's Seasonal Influenza Vaccine Program (IVP)?

    The primary goal is to vaccinate 100 percent of all Active Duty, National Guard, Reserve, and Health Care Providers whom provide direct patient care with a milestone goal of ≥ 90 percent by 16 December this year.